Page last updated: 2024-10-16

quinacrine and Cancer of Head

quinacrine has been researched along with Cancer of Head in 2 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hembram, KC1
Chatterjee, S1
Sethy, C1
Nayak, D1
Pradhan, R1
Molla, S1
Bindhani, BK1
Kundu, CN1
Friedman, J1
Nottingham, L1
Duggal, P1
Pernas, FG1
Yan, B1
Yang, XP1
Chen, Z1
Van Waes, C1

Other Studies

2 other studies available for quinacrine and Cancer of Head

ArticleYear
Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer.
    Molecular pharmaceutics, 2019, 07-01, Volume: 16, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlo

2019
Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Nov-15, Volume: 13, Issue:22 Pt 1

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cy

2007